Medical Devices

Here are your up-to-date news results!
Clicking the title of the article will give you the original publication.
You can share an article quickly with colleagues via Twitter and LinkedIn!


Canon Medical’s ultrasound platform provides greater visualization
Published:

Canon Medical Systems USA, Inc. will showcase its premium Aplio i-series ultrasound platform with updated features, including two new transducers and enhanced reporting tools, at this year’s Radiological

The post Canon Medical’s ultrasound platform provides greater visualization appeared first on NS Medical Devices.

Canon Medical’s ultrasound platform provides greater visualization
Published:

Canon Medical Systems USA, Inc. will showcase its premium Aplio i-series ultrasound platform with updated features, including two new transducers and enhanced reporting tools, at this year’s Radiological

The post Canon Medical’s ultrasound platform provides greater visualization appeared first on NS Medical Devices.

BioVentrix announces publication of positive one-year outcomes for Revivent TC System
Published:

BioVentrix, developer of the first less invasive system for left ventricular remodeling, today announced online publication of positive one-year results from its CE Mark study of the Revivent

The post BioVentrix announces publication of positive one-year outcomes for Revivent TC System appeared first on NS Medical Devices.

Biotricity develops new ECG patch platform Biopatch for cardiac patients
Published:

US-based medical technology company Biotricity has completed the development of its new ECG patch platform, Biopatch, which is intended for patients with less complicated cardiac conditions. Biotricity has

The post Biotricity develops new ECG patch platform Biopatch for cardiac patients appeared first on NS Medical Devices.

BioVentrix announces publication of positive one-year outcomes for Revivent TC System
Published:

BioVentrix, developer of the first less invasive system for left ventricular remodeling, today announced online publication of positive one-year results from its CE Mark study of the Revivent

The post BioVentrix announces publication of positive one-year outcomes for Revivent TC System appeared first on NS Medical Devices.

Latest thinking and events
Published:

Biotricity develops new ECG patch platform Biopatch for cardiac patients
Published:

US-based medical technology company Biotricity has completed the development of its new ECG patch platform, Biopatch, which is intended for patients with less complicated cardiac conditions. Biotricity has

The post Biotricity develops new ECG patch platform Biopatch for cardiac patients appeared first on NS Medical Devices.

Venclose gets $27mm via Series C round
Published: 6 Dec 2019 | 0:40 UTC

Venclose Inc. raised $27mm in its Series C financing round led by Ally Bridge Group.

Venclose gets $27mm via Series C round
Published: 6 Dec 2019 | 0:40 UTC

Venclose Inc. raised $27mm in its Series C financing round led by Ally Bridge Group.

Irish growth opportunities highlighted at Medtech Rising
Published: 5 Dec 2019 | 14:34 UTC

The Irish Medtech Association, the Ibec group that represents the medtech sector, Enterprise Ireland and IDA Ireland has highlighted global growth opportunities for the Irish medtech industry at Medtech Rising: The Irish Medtech CEO Conference.

Prostate cancer: Home urine test could 'revolutionize diagnosis'
Published: 5 Dec 2019 | 11:00 UTC

A recent study has investigated a simpler way of testing urine for prostate cancer. The new test would avoid the need for digital rectal examination.

Medical device industry sees 12.7% rise in deal activity - GlobalData
Published: 5 Dec 2019 | 10:07 UTC

Europe’s medical devices industry saw a rise of 12.7% in overall deal activity during Q3 2019, when compared to the four-quarter average, according to GlobalData’s deals database.

Collaboration established to deliver federated learning in life sciences
Published: 5 Dec 2019 | 9:34 UTC

Owkin, which is developing federated learning and AI technologies to advance medical research, has announced a collaboration with technology firm NVIDIA and King’s College London (KCL) to deliver federated learning in healthcare and life sciences.

Series D brings in $80.25mm for Impulse Dynamics
Published: 5 Dec 2019 | 0:40 UTC

Cardiovascular device maker Impulse Dynamics raised $80.25mm in its Series D financing led by Amzak Health Investors, which was joined by other first-time backers Wellington Management, Kennedy Lewis Investment Management, Acorn Biosciences, Minth Holdings, Zoll Medical, Abiomed, an undisclosed corporate investor, and Impulse Dynamics’ CEO and CFO. The company will use the proceeds for US commercialization of its Optimizer implantable smart system, which uses cardiac contractility modulation (CCM) technology to treat chronic heart failure.

Series D brings in $80.25mm for Impulse Dynamics
Published: 5 Dec 2019 | 0:40 UTC

Cardiovascular device maker Impulse Dynamics raised $80.25mm in its Series D financing led by Amzak Health Investors, which was joined by other first-time backers Wellington Management, Kennedy Lewis Investment Management, Acorn Biosciences, Minth Holdings, Zoll Medical, Abiomed, an undisclosed corporate investor, and Impulse Dynamics’ CEO and CFO. The company will use the proceeds for US commercialization of its Optimizer implantable smart system, which uses cardiac contractility modulation (CCM) technology to treat chronic heart failure.

SI-BONE Names Jeryl (“Jeri”) Hilleman to Board of Directors
Published: 4 Dec 2019 | 0:00 UTC

SI-BONE, Inc.,, a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, announced that Jeri Hilleman has joined its Board of Directors, effective immediately.

These blood markers may indicate a higher risk of disease and death
Published: 3 Dec 2019 | 17:00 UTC

New research suggests that certain immune markers in people's blood could help identify those at higher risk of disease and disease-related death.

SI-BONE to Participate at the 31st Annual Piper Jaffray Healthcare Conference on December 5, 2019
Published: 3 Dec 2019 | 0:00 UTC

SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that management will participate in the upcoming 31st Annual Piper Jaffray Healthcare Conference in New York.

Hogan Lovells obtains dismissal of all remaining charges against former New York State Assemblyman
Published: 3 Dec 2019 | 0:00 UTC

2 December 2019 – A New York State Supreme Court judge in Manhattan has dismissed all remaining charges against former New York State Assemblyman Alec Brook-Krasny in a long-running...

Soliton Initiates Significant Step Towards Commercialization
Published: 3 Dec 2019 | 0:00 UTC

Engages Tailfin to Support Brand Development Effort for Limited Launch in Tattoo Removal

What to know about angioplasty
Published: 28 Nov 2019 | 21:00 UTC

Angioplasty is a medical procedure that opens a blocked or narrowed artery close to the heart. Learn about the procedure, the types, recovery, and risks here.

A further step towards an EU-wide collective action
Published: 28 Nov 2019 | 0:00 UTC

Today representatives of EU member states agreed on a mutual position regarding the Commission's Proposal for a Directive on representative actions for the protection of the collective...

Organogensis completes FOPO; nets $42.4mm
Published: 26 Nov 2019 | 5:40 UTC

Organogenesis Holdings Inc. netted $42.4mm through the public offering of 9mm common shares at $5. The company is developing biomaterials for the advanced wound care and surgical and sports markets, and will use the proceeds for continued product development, manufacturing, and commercialization support.

Organogensis completes FOPO; nets $42.4mm
Published: 26 Nov 2019 | 5:40 UTC

Organogenesis Holdings Inc. netted $42.4mm through the public offering of 9mm common shares at $5. The company is developing biomaterials for the advanced wound care and surgical and sports markets, and will use the proceeds for continued product development, manufacturing, and commercialization support.

Dare acquires Microchips to enhance contraceptive offerings
Published: 22 Nov 2019 | 5:40 UTC

Dare Bioscience Inc. acquired private Microchips Biotech Inc. (wireless implantable microchip drug delivery technology) in a stock transaction with the potential for earn-outs.

ICU Medical buys HD catheter infection-prevention device firm Pursuit Vascular for up to $125mm
Published: 20 Nov 2019 | 5:40 UTC

ICU Medical Inc. agreed to acquire privately held Pursuit Vascular Inc. (device to reduce catheter-related bloodstream infections (CRBSIs) in hemodialysis (HD) patients).

Antares, Idorsia team up to develop drug-device combo product for myocardial infarction
Published: 20 Nov 2019 | 5:40 UTC

Idorsia Pharmaceuticals Ltd. and Antares Pharma Inc. are teaming up to develop a drug-device product that delivers Idorsia’s selatogrel using Antares’ subcutaneous QuickShot auto-injector for adults with suspected acute myocardial infarction (AMI).

Stryker buys Wright Medical Group; enterprise value of $5.4bn
Published: 7 Nov 2019 | 5:40 UTC

Stryker Corp. is paying $30.75 per share (a 50% premium) or $4.7bn to acquire fellow public orthopedics firm Wright Medical Group NV. The deal has a total enterprise value of about $5.4bn (including convertible notes).

Google Buys Fitbit for $2.1B
Published: 4 Nov 2019 | 19:39 UTC

Wearable fitness products company Fitbit Inc. announced Friday it entered a definitive agreement to be acquired by Alphabet Inc.-owned Google for $7.35 per share in cash, valuing the company at approximately $2.1 billion. James Park, co-founder

The post Google Buys Fitbit for $2.1B appeared first on Knobbe Medical.

Bryn licenses exclusive global rights to Aptar's bidose nasal delivery device
Published: 26 Oct 2019 | 3:40 UTC

Bryn Pharma LLC licensed exclusive global rights to use Aptar Pharma’s bidose (BDS) nasal device to deliver its epinephrine nasal spray BRYN-NDS1C.

Bausch & Lomb gets US and Canadian rights to Clearside's Xipere
Published: 26 Oct 2019 | 3:40 UTC

Clearside Biomedical Inc. licensed Bausch & Lomb Inc. exclusive rights to develop, manufacture, and commercialize Xipere (triamcinolone acetonide) suprachoroidal injectable suspension for macular edema and uveitis in the US and Canada.

FDA Issues Guidance on “Abbreviated” and “Special” 510(k) Pathways
Published: 18 Sep 2019 | 12:00 UTC

The U.S. Food and Drug Administration (FDA) has issued two new guidance documents related respectively to an “abbreviated” and a “special” approach to the typical 510(K) process for medical devices.

The FDA describes

The post FDA Issues Guidance on “Abbreviated” and “Special” 510(k) Pathways appeared first on Knobbe Medical.

PTAB Institutes Inter Partes Review of Medtronic “Jervis” Patent
Published: 26 Jun 2019 | 21:27 UTC

On June 11, 2019, the U.S. Patent and Trademark Office Patent Trial and Appeal Board (PTAB) instituted inter partes review (IPR) of U.S. Patent No. 6,306,141, assigned to Medtronic Vascular, Inc.  The Decision instituted the IPR based on

The post PTAB Institutes Inter Partes Review of Medtronic “Jervis” Patent appeared first on Knobbe Medical.

How digital is changing the pharma and healthcare industry
Published: 21 May 2019 | 10:44 UTC

Sharda Hospital discuss six growing trends of digital adoption in pharma and healthcare and discuss the implications for the industry

UK medtech: are we neglecting inclusivity for the sake of innovation?
Published: 1 May 2019 | 8:58 UTC

Hilary Stephenson, Managing Director of Sigma, discusses whether the advancements in med tech exclude vulnerable members of society

Med Tech Highlights at CES 2019: What does this innovation mean for the future o...
Published: 19 Feb 2019 | 13:48 UTC

Shravan Kumar shares the innovators that turned heads at this year's Consumer Electronics Summit



Please note that GR Consulting can not alter or influence the messages displayed, nor is it responsible for its content. If needed or desired, please refer to the original message and/or its originator.